Merck Keytruda Reduces Cervical Cancer Mortality Risk (NYSE:MRK)
Various photographs Merck (New York Stock Exchange:MRK) announced Saturday that its anti-PD-1 therapy Keytruda (pembrolizumab) met the primary endpoint in ...
Tag: Cervical
Corbus Describes Phase 1 Results of ADC Trial for Bladder and Cervical Cancers
free of law Corbus Pharmaceuticals (NASDAQ:CRBP) said its antibody-drug conjugate, CRB-701, demonstrated promising efficacy and safety data in a Phase ...
Recommended.
